tiprankstipranks
Trending News
More News >
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
US Market

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

Compare
670 Followers

Galectin Therapeutics (GALT) Ownership Overview

28.21%3.85%2.83%3.26%61.84%
28.21% Insiders
2.83% Other Institutional Investors
3.26% ETFs
61.84% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 9.95% of the company’s stock is owned by Institutional Investors, 28.21% is owned by Insiders, and 61.84% is owned by Public Companies and Individual Investors.
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 6.68% of the company’s stock is owned by Institutional Investors, 28.21% is owned by Insiders, and 3.26% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 09, 2026
xxxxxxxxxxxxx
$810
Jan 13, 2026
xxxxxxxxxxxxx
$218568
Dec 23, 2025
xxxxxxxxxxxxx
$2611
Dec 23, 2025
xxxxxxxxxxxxx
$19470

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,360,386Insider16.07%29,112,685
5,614,457Insider8.71%15,776,624
1,915,073Institution2.97%5,381,355
1,899,114Institution2.95%5,336,510
1,045,541Insider1.62%2,937,970
778,260Insider1.21%2,186,911
485,618Institution0.75%1,364,587
137,269Insider0.21%385,726
124,684Institution0.19%350,362
70,107Insider0.11%197,001

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,899,114Institution2.95%5,336,510
485,618Institution0.75%1,364,587
44,970Institution0.07%126,366
26,902Institution0.04%75,595
24,567Institution0.04%69,033
1,177Institution<0.01%3,307
289Institution<0.01%812
198Institution<0.01%556

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,351,443Institution2.10%5,622,003
563,630Institution0.87%2,344,701
123,144Institution0.19%346,035
51,484Institution0.08%142,096
11,267Institution0.02%31,660

FAQ

Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 2.83% of the company's stock is held by institutional investors, 28.21% is held by insiders, and 61.84% is held by retail investors.
    What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.83% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 61.84% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics Inc (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics Inc (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.